These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 17000662)

  • 21. CUDC-305, a novel synthetic HSP90 inhibitor with unique pharmacologic properties for cancer therapy.
    Bao R; Lai CJ; Qu H; Wang D; Yin L; Zifcak B; Atoyan R; Wang J; Samson M; Forrester J; DellaRocca S; Xu GX; Tao X; Zhai HX; Cai X; Qian C
    Clin Cancer Res; 2009 Jun; 15(12):4046-57. PubMed ID: 19509149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular aspects of carcinogenesis in pancreatic cancer.
    Koliopanos A; Avgerinos C; Paraskeva C; Touloumis Z; Kelgiorgi D; Dervenis C
    Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):345-56. PubMed ID: 18693168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcriptional cooperation between the transforming growth factor-beta and Wnt pathways in mammary and intestinal tumorigenesis.
    Labbé E; Lock L; Letamendia A; Gorska AE; Gryfe R; Gallinger S; Moses HL; Attisano L
    Cancer Res; 2007 Jan; 67(1):75-84. PubMed ID: 17210685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wilms' tumor gene WT1-shRNA as a potent apoptosis-inducing agent for solid tumors.
    Tatsumi N; Oji Y; Tsuji N; Tsuda A; Higashio M; Aoyagi S; Fukuda I; Ito K; Nakamura J; Takashima S; Kitamura Y; Miyai S; Jomgeow T; Li Z; Shirakata T; Nishida S; Tsuboi A; Oka Y; Sugiyama H
    Int J Oncol; 2008 Mar; 32(3):701-11. PubMed ID: 18292948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Molecular cancer biology--from research to clinical practice].
    Nielsen FC
    Ugeskr Laeger; 2003 Feb; 165(9):897-900. PubMed ID: 12661511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MAD2DeltaC induces aneuploidy and promotes anchorage-independent growth in human prostate epithelial cells.
    To-Ho KW; Cheung HW; Ling MT; Wong YC; Wang X
    Oncogene; 2008 Jan; 27(3):347-57. PubMed ID: 17621272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. General morphological and biological features of neoplasms: integration of molecular findings.
    Diaz-Cano SJ
    Histopathology; 2008 Jul; 53(1):1-19. PubMed ID: 18282144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular pathways in tumor progression: from discovery to functional understanding.
    Ali MA; Sjöblom T
    Mol Biosyst; 2009 Sep; 5(9):902-8. PubMed ID: 19668850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of genes potentially involved in the acquisition of androgen-independent and metastatic tumor growth in an autochthonous genetically engineered mouse prostate cancer model.
    Morgenbesser SD; McLaren RP; Richards B; Zhang M; Akmaev VR; Winter SF; Mineva ND; Kaplan-Lefko PJ; Foster BA; Cook BP; Dufault MR; Cao X; Wang CJ; Teicher BA; Klinger KW; Greenberg NM; Madden SL
    Prostate; 2007 Jan; 67(1):83-106. PubMed ID: 17013881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dietary induction of colonic tumors in a mouse model of sporadic colon cancer.
    Yang K; Kurihara N; Fan K; Newmark H; Rigas B; Bancroft L; Corner G; Livote E; Lesser M; Edelmann W; Velcich A; Lipkin M; Augenlicht L
    Cancer Res; 2008 Oct; 68(19):7803-10. PubMed ID: 18829535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
    Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hallmarks for senescence in carcinogenesis: novel signaling players.
    Caino MC; Meshki J; Kazanietz MG
    Apoptosis; 2009 Apr; 14(4):392-408. PubMed ID: 19169823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sustained TGF beta exposure suppresses Smad and non-Smad signalling in mammary epithelial cells, leading to EMT and inhibition of growth arrest and apoptosis.
    Gal A; Sjöblom T; Fedorova L; Imreh S; Beug H; Moustakas A
    Oncogene; 2008 Feb; 27(9):1218-30. PubMed ID: 17724470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
    Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
    Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modeling cancer in mice.
    Jackson-Grusby L
    Oncogene; 2002 Aug; 21(35):5504-14. PubMed ID: 12154411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid induction of malignant tumor in Sprague-Dawley rats by injection of RK3E-ras cells.
    Kim SA; Kim HW; Kim DK; Kim SG; Park JC; Kang DW; Kim SW; Ahn SG; Yoon JH
    Cancer Lett; 2006 Apr; 235(1):53-9. PubMed ID: 15899546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using Drosophila melanogaster to map human cancer pathways.
    Brumby AM; Richardson HE
    Nat Rev Cancer; 2005 Aug; 5(8):626-39. PubMed ID: 16034367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional genetics and experimental models of human cancer.
    Zhao JJ; Roberts TM; Hahn WC
    Trends Mol Med; 2004 Jul; 10(7):344-50. PubMed ID: 15242683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A 4-mutation model of carcinogenesis for tumour suppressor genes.
    Den Otter W; Koten JW
    Anticancer Res; 1999; 19(6A):4845-52. PubMed ID: 10697598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.